Neuraminidase inhibitors in pandemic A/H1N1 flu

BMJ (Online)

Volumn 340, Issue 7738, 2010, Pages 115-

  Weber, J Todd ^a   Nicoll, Angus ^a   Bridges, Carolyn B ^b   Ciancio, Bruno C ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; ANTIVIRUS AGENT; ENZYME INHIBITOR; SIALIDASE;

ADVERSE OUTCOME; ANTIVIRAL THERAPY; DRUG EFFICACY; DRUG SAFETY; HUMAN; INFLUENZA; INFLUENZA VIRUS A H1N1; LETTER; PANDEMIC; PRIORITY JOURNAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; DRUG ANTAGONISM; EPIDEMIC; NOTE;

ANTIVIRAL AGENTS; DISEASE OUTBREAKS; ENZYME INHIBITORS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; NEURAMINIDASE; OSELTAMIVIR;

EID: 75649097154     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c130     Document Type: Letter

References (6)

1. Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009;339:b5106. (8 December.) [Abstract/Free Full Text]
2. Uyeki T. Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). N Eng J Med 2009;361:e110. Epub 2009 Nov 18.[Free Full Text]
3. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al, 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-44.[Abstract/Free Full Text]
4. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009;302:1880-7.[Abstract/Free Full Text]
5. Lee N, Cockram CS, Chan PK, Hui DS, Choi KW, Sung JJ. Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes. Clin Infect Dis 2008;46:1323-4. [CrossRef][Web of Science][Medline]
6. MHRA. UK suspected adverse drug reaction (ADR) analysis. Influenza antivirals-oseltamivir (Tamiflu) and zanamivir (Relenza). 26 November 2009. Available from: www.mhra.gov.uk/home/idcplg?IdcService=GET-FILE&dDocName= CON062908&RevisionSelectionMethod=Latest